The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are soliciting research and development proposals from small businesses to support innovations that will contribute to improved health security.
Participating components in this Small Business Innovation Research (SBIR) funding effort include the National Cancer Institute; National Institute of Allergy and Infectious Diseases; CDC Center for Global Health; National Center for Emerging Zoonotic and Infectious Diseases; and the National Center for Immunization and Respiratory Diseases.
Highlighted topics of interest include:
- Diagnostic Tools to Support Elimination/Control of Neglected Tropical Diseases
- Validation of Mobile Technologies for Clinical Assessment
- Telemonitoring for Infectious Diseases
- Immunization Against Rotavirus Using a Dissolvable Microneedle Patch
- Vaccines against Pathogens with Small Market Potential
- Predictive Biomarkers of Adverse Reactions to Radiation Treatment
- Signal Amplification to Enable Attomolar Quantitation in ELISA Biomarker Immunoassays
- Development of Stem Cell-based Assay for High-Throughput Toxicological Screening
- Simple, Inexpensive Device to Purify DNA from Sputum for Tuberculosis Testing
- Development of Smart Plate Technology
- Innovative Oral Formulations for Anti-Infective Drugs
- De novo Assembly of Arthropod Genomes of Public Health Importance
- Detecting Lower Intestinal Microbiome Disruption
- Detection of Multidrug Resistant Organisms
- Serologic Detection and Quantification of Hepatitis B Core Antigen
- Thermostable Dry Powder Live Attenuated Influenza Vaccine for Nasal Delivery
Some topic areas are eligible as Fast Track Proposals; in this case firms may simultaneously submit both Phase 1 and Phase 2 proposals for funding consideration.
Further details are available via Solicitation Number: PHS-2016-1. Proposals are due October 16, 2015.
